학술논문

Design of Effisayil (TM) 2: A Randomized, Double-Blind, Placebo-Controlled Study of Spesolimab in Preventing Flares in Patients with Generalized Pustular Psoriasis
Document Type
Journal
Source
DERMATOLOGY AND THERAPY; NOV 5 2022, 13p.
Subject
Language
English
ISSN
21909172